GASTALDELLI, AMALIA
 Distribuzione geografica
Continente #
AS - Asia 301
NA - Nord America 119
EU - Europa 39
Totale 459
Nazione #
SG - Singapore 264
US - Stati Uniti d'America 119
IT - Italia 30
CN - Cina 26
KR - Corea 9
FR - Francia 3
GB - Regno Unito 3
GR - Grecia 2
AT - Austria 1
JP - Giappone 1
TR - Turchia 1
Totale 459
Città #
Singapore 219
Santa Clara 40
Guangzhou 14
Seoul 9
Cascina 6
Florence 4
Altamura 3
Pontedera 3
Seravezza 3
Athens 2
Forest City 2
London 2
Pisa 2
Rome 2
Turin 2
Ashburn 1
Birmingham 1
Fort Worth 1
Rosolini 1
Springfield 1
Tokyo 1
Verona 1
Vienna 1
Totale 321
Nome #
ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model 9
Changes in plasma bioactive lipids and inflammatory markers during a half-marathon in trained athletes 6
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests 6
CISAS-WP4: studi di epidemiologia eziologica nei SIN di Priolo, Milazzo e Crotone. 5
A model for glucose control of insulin secretion during 24 h of free living 5
Biomarkers of exposure and early effect in three contaminated sites of southern Italy: protocols for etiological epidemiological studies 5
New insights on the interactions between insulin clearance and the main glucose homeostasis mechanisms 4
Exposure profiles in pregnant women from a birth cohort in a highly contaminated area of southern Italy 4
Decreased whole-body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients 4
Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study 4
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease 4
Altered metabolic profile and adipocyte insulin resistance mark severe liver fibrosis in patients with chronic liver disease 4
The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases 4
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with NASH 3
Healthy aging: the INTECMAN project 3
A minimal model of glucose absorption, production and disappearance for double-tracer oral glucose tolerance tests 3
Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models 3
Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW 3
Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes 3
Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial 3
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile 3
Biomarkers of exposure and early effect in three contaminated sites of southern Italy: Protocols for etiological epidemiological studies 3
A new approach to study in vivo cellular metabolism using a modellistic analysis of magnetic resonance spectra 3
Phthalates exposure as determinant of albuminuria in subjects with type 2 diabetes: A cross-sectional study 3
Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk 3
The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF 3
PPAR-?-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH 3
Healthy aging: the INTECMAN project 3
Thiazolidinediones improve beta-cell function in type 2 diabetic patients 3
Insulin: new roles for an ancient hormone 3
Moving medical semeiotics to the digital realm: SEMEOTICONS approach to face signs of cardiometabolic risk 3
Advanced glycation end products, leukocyte telomere length, and mitochondrial DNA copy number in patients with coronary artery disease and alterations of glucose homeostasis: From the GENOCOR study 3
Direct effect of GLP-1 infusion on endogenous glucose production in humans 3
Evaluation of published clinical scores for the prediction of cardiometabolic risk in the SEMEOTICONS project 3
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C 3
Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance 3
Pathogenesis and Clinical Features of Obesity and Insulin Resistance 3
Increased FNDC5/Irisin expression in human hepatocellular carcinoma 3
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy 3
Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects 3
SGLT2 inhibitors and thiazide enhance excretion of DEHP toxic metabolites in subjects with type 2 diabetes: A randomized clinical trial 3
Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician 3
From MASTIHA to MAST4HEALTH: Report from the Secondment Experience 3
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy 3
Circulating levels of adiponectin increase in patients with idiopathic dilated cardiomyopathy with and without overt heart failure 3
Linear and nonlinear properties of heart rate variability: Influence of obesity 3
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (vol 7, 12200, 2017) 3
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P 3
Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome 3
Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes 3
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus 3
Both Insulin Resistance and Alanine Aminotransferase Level Increase the Risks of Cardiovascular Disease in Fatty Liver Disease Reply 3
Assessment of methods for improving tracer estimation of non-steady-state rate of appearance 3
Visceral fat and beta cell function in non diabetic humans 3
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease 2
The Nonalcoholic Steatohepatitis Metabotype: Imbalance of Circulating Amino Acids and Transamination Reactions Reflect Impaired Mitochondrial Function REPLY 2
Long-term effects of bariatric surgery on meal disposal and ss-cell function in diabetic and nondiabetic patients 2
Relationship between fatty liver and glucose metabolism: A cross-sectional study in 571 obese children 2
Impact of PPAR-gamma agonists on adipose-tissue insulin resistance in patients with IGT or T2DM and non-alcoholic steatohepatitis (NASH) 2
STUDY OF GLUCOSE AND GLYCEROL KINETICS DURING FASTING AND HYPERINSULINEMIA BY COMPARTMENTAL ANALYSIS USING SAAM-II 2
CHANGES IN TRACER INFUSION RATES TO MINIMIZE THE STRUCTURAL ERROR IN STEELES MODEL 2
Inflammatory Biomarkers are Correlated with Some Forms of Regressive Autism Spectrum Disorder 2
Chapter 8. Risk Relationship between Insulin Resistance, Diabetes, and Atherosclerotic Cardiovascular Disease 2
Metabolic response to high-carbohydrate and low-carbohydrate meals in a nonhuman primate model 2
Why does obesity cause diabetes? 2
The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo 2
Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with Type 2 diabetes: a double tracer OGTT study 2
Mechanisms for increased risk of diabetes in chronic liver diseases 2
Zusammenhang von Fatty Liver Index mit metabolischen Parametern und Diabetesrisiko bei Frauen nach Gestationsdiabetes 2
Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats 2
The role of cardiac fat in insulin resistance 2
Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women 2
Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat 2
Small intestinal metabolism is central to whole-body insulin resistance 2
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease 2
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk 2
Anti-inflammatory Effects of omega-3 polyunsaturated Fatty Acid and Hydroxytyrosol in Murine 3T3-L1 Adipocytes - A Protective Mechanism of Mediterranean Diets in Obesity 2
An accurate and robust method for unsupervised assessment of abdominal fat by MRI 2
[11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia 2
A single mechanism underlies glucose kinetics in euglycaemic and hyperglycaemic clamps and oral glucose tolerance tests 2
Insulin: The master regulator of glucose metabolism 2
A modellistic view of the kinetics of metabolic processes: differences in the glucose and xylose degradation pathway 2
Effect of acute hyperglycemia on insulin secretion in humans 2
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD 2
Fatty liver disease: the hepatic manifestation of metabolic syndrome 2
Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic risk. 2
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis 2
INFLUENCE OF ETHNICITY AND FAMILIAL DIABETES ON PERIPHERAL AND HEPATIC INSULIN ACTION 2
Association of fatty liver index (FLI) with parameters of insulin sensitivity in women with prior gestational diabetes 2
Krill oil supplementation reduces exacerbated hepatic steatosis induced by thermoneutral housing in mice with diet-induced obesity 2
18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study 2
Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass 2
Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis 2
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: A physiological analysis 2
Osteoprotegerin as a marker of atherosclerosis and severity of CAD in patients candidate to cardiac imaging. 2
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 2
OBESITY PER SE IS A MAJOR STIMULUS FOR GLUCONEOGENESIS 2
Brown versus white fat: are they really playing a role in obesity and cardiometabolic risk? "Brown adipose tissue plays a key role in thermogenesis..." 2
The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice 2
Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy 2
Totale 279
Categoria #
all - tutte 5.345
article - articoli 4.874
book - libri 11
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 74
Totale 10.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202461 0 0 0 0 0 0 0 0 4 1 43 13
2024/2025406 21 36 349 0 0 0 0 0 0 0 0 0
Totale 467